Pharmaceutical Technology-01-02-2021

January 03, 2021

Biopharma looks to deliver on COVID-19 vaccines and other promising therapies.

January 03, 2021

Despite the COVID-19 pandemic disruptions, with continued support and industry resilience, the European bio/pharma outlook for 2021 is positive.

January 03, 2021

Essential bio/pharma employees show hard work and dedication can pay off for patients.

January 03, 2021

Demand for specific advanced laboratory skills drives creates a positive employment market.

January 03, 2021

To restrict the use of intentionally added microplastics, the European Chemicals Agency has proposed a restriction dossier that describes various measures aimed at minimizing the use of microplastics in various industrial segments, including pharmaceuticals. In this paper, the authors discuss these restrictions.

January 03, 2021

FDA approval rate speeds up despite COVID-19 complications.

January 03, 2021

The right partner can help companies overcome key formulation challenges for biologic drugs.

January 03, 2021

Consider a matrix of factors when choosing what type of cleanroom facility to construct.

January 03, 2021

As the first wave of mRNA vaccines are distributed, efforts will be needed to protect data and prevent errors.

January 03, 2021

During the COVID-19 pandemic, when inspectors cannot visit sites directly, FDA is relying on other global inspection reports and remote document review, yet does not consider them equivalent to on-site inspections. Manufacturers await more clarity.

January 02, 2021

Positive regulatory developments are aiding the growth of the cannabis pharmaceuticals market, but more clinical data are needed to break the stigma and bring science to the fore.

January 02, 2021

EMA’s SPOR implementation guide version two is expected to be published soon, starting the countdown for companies to ensure their data-based submissions are compliant.

January 02, 2021

Traditional biologic-based testing methods may need an upgrade to properly test newer therapeutic modalities.

January 02, 2021

Outsourcing increases as the industry balances development and manufacturing of both COVID-19 treatments and non-pandemic-related medicines.

January 02, 2021

The incoming administration faces key decisions on drug testing and access as well as vaccine distribution challenges.

January 02, 2021

The recently published European pharmaceutical strategy is being seen as an opportunity to strengthen medicines regulation in the region.

January 02, 2021

The outlook for the European pharma industry is appearing to be favourable overall.

January 02, 2021

Shutting down the COVID-19 pandemic requires a global, selfless effort.

January 02, 2021

Updating the quality technical agreement will clarify any expectations and limitations, says Siegfried Schmitt, vice president, Technical at Parexel.

January 02, 2021

GEMÜ’s process solenoid valve with pressure compensation, the GEMÜ M75, uses a double bellows principle to balance pressure forces, which allows the valve to be used for processes with an operating pressure of up to 6 bar.

January 02, 2021

Boreas from Telstar are -86 ºC ultra-low-temperature freezers developed to house COVID-19 vaccines.

January 02, 2021

The new Sanitary Rotary Batch Mini Mixer from Munson Machinery Company has the ability to de-agglomerate and blend up to 5 ft3 (142 ℓ) of dry bulk ingredients with or without liquid additions at several locations.

January 02, 2021

ROSS’ Sanitary Ribbon Blenders with ergonomic material handling accessories feature a new design that allows operators to safely empty bags of powder through a bar grating while an adjacent vibrating tray assembly catches debris and off-spec ingredients.

January 02, 2021

The number of recommendations for European marketing authorization of human medicines saw significant increase in 2020 over the previous year.